Evidence map›Paper›PMID 33892961›Full record

ArticleSeminars in perinatology2021

Telemedicine use in neonatal follow-up programs - What can we do and what we can't - Lessons learned from COVID-19.

Sara B DeMauro, Andrea F Duncan, Hallam Hurt

Abstract read
In one paragraph

Article in Seminars in perinatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. The future of follow-up: technology-enabled medical and developmental follow-up care for NICU graduates.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Usability and Feasibility of an in-Home Remote Exam Device in Children with Medical Complexity During the COVID-19 Pandemic.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Telemedicine across the continuum of neonatal-perinatal care.Seminars in fetal & neonatal medicine · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sara B DeMauroChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, 2716 South Street, Philadelphia, PA 19146, United States. Electronic address: DeMauro@chop.edu.
Andrea F DuncanChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, 2716 South Street, Philadelphia, PA 19146, United States.
Hallam HurtChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, 2716 South Street, Philadelphia, PA 19146, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to this population. In this article we discuss our institution's experience with rapid implementation of telemedicine in a multi-site neonatal follow-up program as well as benefits and limitations of the use of telemedicine in this context. Finally, we discuss the current problems that must be solved in order to optimize telemedicine as a tool for providing comprehensive, multidisciplinary medical and developmental care to high risk infants and their families.

Indexed as

AftercareCOVID-19Infant CareTelemedicineChild DevelopmentFamily HealthHumansInfant, NewbornInfant, Newborn, DiseasesInfant, PrematurePatient Care TeamProgram EvaluationRisk AssessmentSARS-CoV-2United States

Identifiers

PMID33892961
PMCPMC8022519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.